awmsg logo



bedaquiline (Sirturo®)


Reference No. 1334

Publication date:
20/05/2015


Appraisal information

bedaquiline (Sirturo®) 100 mg tablet


Company: Janssen-Cilag Ltd
BNF category: Infections
NMG meeting date: 25/02/2015
AWMSG meeting date: 25/03/2015
   
   
Submission Type: Full Submission
Status: Recommended
Advice No: 0815
Ministerial ratification: 15/05/2015

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Bedaquiline (Sirturo®) is recommended as an option for use within NHS Wales for use as part of an appropriate combination regimen for pulmonary multidrug resistant tuberculosis in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download